Srivichaivejvivat Public Company Limited

SET:VIH-R Stock Report

Market Cap: ฿5.8b

Srivichaivejvivat Future Growth

Future criteria checks 2/6

Srivichaivejvivat is forecast to grow earnings and revenue by 3.6% and 7.6% per annum respectively. EPS is expected to grow by 2.1% per annum. Return on equity is forecast to be 9.5% in 3 years.

Key information

3.6%

Earnings growth rate

2.1%

EPS growth rate

Healthcare earnings growth9.4%
Revenue growth rate7.6%
Future return on equity9.5%
Analyst coverage

Low

Last updated13 Nov 2024

Recent future growth updates

No updates

Recent updates

Earnings and Revenue Growth Forecasts

SET:VIH-R - Analysts future estimates and past financials data (THB Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20263,435361-2456011
12/31/20253,168388-1,1985941
12/31/20242,9693403745171
9/30/20242,883342329528N/A
6/30/20242,876335253503N/A
3/31/20242,826317167442N/A
12/31/20232,761284105384N/A
9/30/20232,673248333636N/A
6/30/20232,677252672920N/A
3/31/20232,970363176714N/A
12/31/20223,662697337940N/A
9/30/20223,7546941,1221,713N/A
6/30/20225,1811,4617401,336N/A
3/31/20225,3941,5651,4081,681N/A
12/31/20214,7301,2551,2851,460N/A
9/30/20214,5511,260232410N/A
6/30/20212,980462292471N/A
3/31/20212,320203177365N/A
12/31/20202,290186118349N/A
9/30/20202,331177229429N/A
6/30/20202,438201252463N/A
3/31/20202,537208225458N/A
12/31/20192,503200154384N/A
9/30/20192,41716925279N/A
6/30/20192,33015531273N/A
3/31/20192,28217024261N/A
12/31/20182,25917638278N/A
9/30/20182,22518153302N/A
6/30/20182,146162N/A298N/A
3/31/20182,081145N/A252N/A
12/31/20171,974125N/A246N/A
9/30/20171,917116N/A234N/A
6/30/20171,879119N/A210N/A
3/31/20171,809137N/A230N/A
12/31/20161,743153N/A250N/A
9/30/20161,648157N/A300N/A
6/30/20161,503130N/A265N/A
3/31/20161,433119N/A263N/A
12/31/20151,369101N/A233N/A
9/30/20151,31588N/A139N/A
6/30/20151,28983N/A163N/A
3/31/20151,28791N/A141N/A
12/31/20141,27694N/A128N/A
9/30/20141,23582N/A162N/A
6/30/20141,19787N/A150N/A
3/31/20141,16071N/A147N/A
12/31/20131,13061N/A143N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: VIH-R's forecast earnings growth (3.6% per year) is above the savings rate (2%).

Earnings vs Market: VIH-R's earnings (3.6% per year) are forecast to grow slower than the TH market (16.9% per year).

High Growth Earnings: VIH-R's earnings are forecast to grow, but not significantly.

Revenue vs Market: VIH-R's revenue (7.6% per year) is forecast to grow faster than the TH market (6.5% per year).

High Growth Revenue: VIH-R's revenue (7.6% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: VIH-R's Return on Equity is forecast to be low in 3 years time (9.5%).


Discover growth companies